Drugs / Sbv
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03023111 Comparator | Jun 2017 → Aug 2019 | cutaneous leishmaniasis | Hospital Universitário Professor Edgard Santos | Completed | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sbv | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03023111 ↗ |
| Route | Intravenous | “intravenously” NCT03023111 ↗ |